specialty drug costs

Sovaldi Tecfidera Imbruvica side by side
Pharma

Secrets of a successful launch? Ask Gilead, Biogen and J&J

An analysis of recently launched meds holds some clues to successful—and not so successful—rollouts.
Eric Sagonowsky Nov 16, 2016 3:08pm
pills money

PBM hardball, specialty med slowdown to curb 2017 spending

Jun 21, 2016 6:01am